Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY

REVIEW ARTICLE

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

Peter W. Collins,on behalf of the UK Haemophilia Centre Doctors’ Organization,Benedict P. Palmer,on behalf of the UK Haemophilia Centre Doctors’ Organization,Elizabeth A. Chalmers,on behalf of the UK Haemophilia Centre Doctors’ Organization,Daniel P. Hart,on behalf of the UK Haemophilia Centre Doctors’ Organization,Ri Liesner,on behalf of the UK Haemophilia Centre Doctors’ Organization,Savita Rangarajan,on behalf of the UK Haemophilia Centre Doctors’ Organization,Katherine Talks,on behalf of the UK Haemophilia Centre Doctors’ Organization,Michael Williams,on behalf of the UK Haemophilia Centre Doctors’ Organization,Charles R. M. Hay,on behalf of the UK Haemophilia Centre Doctors’ Organization
Thierry Calvez,for the FranceCoag Network,Hervé Chambost,for the FranceCoag Network,Ségolène Claeyssens-Donadel,for the FranceCoag Network,Roseline d’Oiron,for the FranceCoag Network,Véronique Goulet,for the FranceCoag Network,Benoît Guillet,for the FranceCoag Network,Virginie Héritier,for the FranceCoag Network,Vanessa Milien,for the FranceCoag Network,Chantal Rothschild,for the FranceCoag Network,Valérie Roussel-Robert,for the FranceCoag Network,Christine Vinciguerra,for the FranceCoag Network,Jenny Goudemand,for the FranceCoag Network

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

Richard F. Schlenk,for the German-Austrian AML Study Group,Sabine Kayser,for the German-Austrian AML Study Group,Lars Bullinger,for the German-Austrian AML Study Group,Guido Kobbe,for the German-Austrian AML Study Group,Jochen Casper,for the German-Austrian AML Study Group,Mark Ringhoffer,for the German-Austrian AML Study Group,Gerhard Held,for the German-Austrian AML Study Group,Peter Brossart,for the German-Austrian AML Study Group,Michael Lübbert,for the German-Austrian AML Study Group,Helmut R. Salih,for the German-Austrian AML Study Group,Thomas Kindler,for the German-Austrian AML Study Group,Heinz A. Horst,for the German-Austrian AML Study Group,Gerald Wulf,for the German-Austrian AML Study Group,David Nachbaur,for the German-Austrian AML Study Group,Katharina Götze,for the German-Austrian AML Study Group,Alexander Lamparter,for the German-Austrian AML Study Group,Peter Paschka,for the German-Austrian AML Study Group,Verena I. Gaidzik,for the German-Austrian AML Study Group,Veronica Teleanu,for the German-Austrian AML Study Group,Daniela Späth,for the German-Austrian AML Study Group,Axel Benner,for the German-Austrian AML Study Group,Jürgen Krauter,for the German-Austrian AML Study Group,Arnold Ganser,for the German-Austrian AML Study Group,Hartmut Döhner,for the German-Austrian AML Study Group,Konstanze Döhner,for the German-Austrian AML Study Group

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

BLOOD WORK

CORRESPONDENCE

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals